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Protein Kinase-Like Non-kinases (PKLNKs), which are closely related to protein kinases, lack the crucial catalytic aspartate in the
catalyticloop,andhencecannotfunctionasproteinkinase,havebeenanalysed.Usingvarioussensitivesequenceanalysismethods,
we have recognized 82 PKLNKs from four higher eukaryotic organisms, namely, Homo sapiens, Mus musculus, Rattus norvegicus,
and Drosophila melanogaster. On the basis of their domain combination and function, PKLNKs have been classiﬁed mainly into
four categories: (1) Ligand binding PKLNKs, (2) PKLNKs with extracellular protein-protein interaction domain, (3) PKLNKs
involved in dimerization, and (4) PKLNKs with cytoplasmic protein-protein interaction module. While members of the ﬁrst two
classes of PKLNKs have transmembrane domain tethered to the PKLNK domain, members of the other two classes of PKLNKs are
cytoplasmic in nature. The current classiﬁcation scheme hopes to provide a convenient framework to classify the PKLNKs from
other eukaryotes which would be helpful in deciphering their roles in cellular processes.
Copyright © 2009 K. Anamika et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
It is now well known that enzymes, in their role as
biocatalysts, are the most important control points in the
living organisms, and the catalytic residues of an enzyme
are key to its molecular function. Bartlett and colleagues
[1] have described pairs of active and inactive enzyme
homologues having same structural scaﬀold but diﬀerent
functions. Catalytically inactive enzyme homologues are
representedinalargevarietyofenzymefamilieswithfamilies
of signaling enzymes having high number of enzymatically
inactive members [2].
Phosphorylation by Ser/Thr/Tyr protein kinases plays a
crucialroleincellularsignaltransduction.Acanonicalkinase
domain consists of 12 subdomains containing few conserved
residues of functional importance. Subdomains I, II, VIB,
and VII are considered to be the most important ones.
Subdomain I includes β-turn structure with 2 or 3 glycine
residues (G-X-G-X-X-G) while subdomain II comprises an
invariant lysine participating in anchoring and orienting the
ATP (Adenosine Tri Phosphate). Subdomain VIB contains
catalytic loop with a key aspartate [D] residue that mediates
the transfer of a phosphate group from ATP to the appropri-
ate substrate. The D residue of DFG motif in subdomain VII
ligatesMg2+whichinturninteractswithβ andγ phosphates
of ATP [3]. Roles of these residues in protein kinases are well
established. The catalytic residues of the protein kinases are
usuallyhighlyconservedtomaintaintheirabilityforeﬃcient
cellular signal transduction. However, there have been few
reports of proteins with substitutions/deletion at essential
catalytic sites. Among these functionally important residues
in a Ser/Thr/Tyr kinase, the aspartate residue in subdomain
VIB acting as catalytic base seems to be most important as
we are not aware of a properly functional kinase which lacks
this residue.
Although the importance of protein kinases has long
been recognized, studies on protein kinase homologues
lacking catalytic residue/residues are more recent. Several
studies on repertoire of kinases in various organisms have
revealed presence of enzymatically inactive homologues of
protein kinases [4–6] which lack catalytic function and
instead serve as scaﬀolds or kinase substrates. Boudeau and
colleagueshavediscussedrolesofhumankinase-likeproteins
in regulating diverse cellular processes [7].2 Comparative and Functional Genomics
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Figure 1: Phylogenetic tree representing catalytic kinase domain and PKLNK domains of mouse. Abbreviations followed in the ﬁgure are
Pkinase, Protein kinase; PKLNK, Protein kinase-like nonkinase.
Despite considerable sequence similarity to enzymati-
cally active protein kinases, Protein Kinase-Like Nonkinase
(PKLNK—also referred as Kinase Homology Domain—
KHD in some of the earlier publications) domains lacking
keyresiduesthoughttohaveregulatoryroles.Someexamples
of proteins containing such domains which lack catalytic
base aspartate are a PKLNK domain tethered to a tyrosine
kinase domain in Janus Kinase (JAK) and membrane
guanylyl cyclases (or particulate guanylyl cyclase) in which
a regulatory PKLNK domain is situated N-terminal to the
guanylyl cyclase domain [8–10]. PKLNK domain in JAK is
thethered to functional kinase domain; however in guanylyl
cyclases (GC), a functional kinase domain is absent, and the
PKLNK is tethered to a cyclase domain. PKLNK domain
of Guanylyl cyclase-A serves as an important mediator
in transducing the ligand-induced signals to activate the
catalytic cyclase domain of the receptor. Deletion of PKLNK
domain from GC-A, -B, and -C resulted in constitutive
activation of these enzymes [11, 12] and is shown to act
as a repressor of the catalytic domain in the basal state
[13]. The PKLNK of guanylyl cyclase-A (Natriuretic peptide
receptor A) is more closely related to protein tyrosine kinase
than protein serine/threonine kinase [11, 12, 14]. PKLNK
in receptor guanylyl cyclase provides a critical structural
link between the extracellular domain and the catalytic
domain in regulating the activity of this family of receptor.
Modeling of the PKLNK of human GC-C indicates that it
can adopt a structure similar to that of tyrosine kinases [15].
There are many other protein kinase-like domains which
lack other catalytically important residues, though playing
important role as regulatory proteins, for example, “dead”
RTK-ErbB3 [16], OTK (Oﬀ Track Kinase), WNK (with noComparative and Functional Genomics 3
Table 1: List of 31 human PKLNKs is represented in the table. Substitutions of various important residues in the motifs which are generally
conserved in the functional protein kinase are shown for each human PKLNK. “-” indicates deletion.
Gene code “HRD” motif in
the catalytic loop
Activation loop start Activation loop end
gi|119534|sp|P21860 HRN DFG ALE
gi|6005792|ref|NP 009130.1 CGS DFA PEE
gi|4758292|ref|NP 004436.1 HRS RLG APE
gi|4758606|ref|NP 004508.1 PRH --- APE
gi|14042287|dbj|BAB55185.1 HGN --SA P E
gi|15779207|gb|AAH14662.1 HNN --GA P E
gi|7020363|dbj|BAA91097.1 YGH DLE ---
gi|7243101|dbj|BAA92598.1 HGN GFD APE
gi|4504217|ref|NP 000171.1 HGR DHG APE
gi|14041796|dbj|BAB55454.1 HNN --GA --
gi|18676872|dbj|BAB85045.1 HRA KFG APE
gi|17368698|sp|Q9BXU1 HGS DF D APE
gi|18386335|gb|AAB19934.2 HGR DFG APE
gi|12052916|emb|CAB66632.1 HRN DFH ---
gi|22760572|dbj|BAC11248.1 HRN DFH APE
gi|4580422|ref|NP 003986.2 HGS DYG APE
gi|13027388|ref|NP 061041.2 HRS --GS P E
gi|22749323|ref|NP 689862.1 HGK GFE SP -
gi|22760645|dbj|BAC11278.1 HRN DFH APE
gi|16306492|ref|NP 203698.1 Deletion --- SPE
gi|115430241 HNN --GA --
gi|134152694 HGR DYG APE
gi|31982929 --- GYG SMD
gi|34191428 HRN D -- APE
gi|40254426 HGN DYG APE
gi|57997202 HR - SPG APE
gi|58530886 HSN --- PED
ENSP00000222246 HGN DPG APE
ENSP00000264818 HGN DPG APE
ENSP00000294423 HGN DPG APE
ENSP00000371067 HGN DPG PPE
lysine kinase), Tribbles, giant muscle protein titin (present
in vertebrates), HER3, CCK-4 (Colon Carcinoma Kinase-
4), Eph (Erythropoietin-producing hepatocyte) family of
receptor tyrosine kinase, h-Ryk/d-Derailed, integrin-linked
kinase (ILK) [17], and so forth. Recently, crystal structure
of ﬁrst PKLNK, VRK3 (a member of the vaccinia-related
kinase family), which lacks aspartate in the catalytic loop
has been reported [18] which revealed that it cannot bind
ATP because of residue substitutions in the binding pocket,
compared to ATP binding homologues. However, VRK3 still
shares prominent structural similarity with enzymatically
active protein kinase.
In the past, our group has reported presence of ABC1,
RIO1, and kinases in archaea and bacteria that share
signiﬁcant similarity with Ser/Thr/Tyr kinase family [19].
The sequences of these protein kinases were examined for
the presence of catalytic aspartate in the catalytic loop.
I-set
fn3 PKLNK fn3 PKLNK
(a)
Guanylate
cyclase 
PKLNK
(b)
TUDOR PKLNK
(c)
Figure 2: Unique domain architectures which are present in
PKLNKandsofarnotreportedintheproteinkinase. Abbreviations
followed in the ﬁgure are I-set, Immunoglobulin I-set; fn3,
Fibronectin 3; PKLNK, Protein Kinase-Like Nonkinase.
Sixteen prokaryotes have been predicted to have at least one
member lacking catalytic aspartate, and the total number of4 Comparative and Functional Genomics
Table 2: List of 18 drosophila PKLNKs. Substitutions of various important residues in the motifs which are generally conserved in the
functional protein kinase are shown for each drosophila PKLNK. “-” indicates deletion.
Gene code “HRD” motif in
the catalytic loop
Activation loop start Activation loop end
gi|17368346|sp|P83097 HRQ VFG APE
gi|21626698|gb|AAF47134.2 HMG DFG SPE
gi|17862032|gb|AAL39493.1 HGS NFS APE
gi|7301824|gb|AAF56933.1 HNN --- SPE
gi|7291217|gb|AAF46649.1 HGK DFG ---
gi|7294467|gb|AAF49811.1 HGA DFG APE
gi|21357711|ref|NP 647767.1 --- --- ---
gi|5052670|gb|AAD38665.1 HGN --- APE
gi|21627748|gb|AAM68879.1 YGH --- AIE
gi|22945875|gb|AAN10635.1 HGH --G ---
gi|23093524|gb|AAN11824.1 HGA DFG APE
gi|23171402|gb|AAF55244.2 HGN DFG APE
gi|21358011|ref|NP 651655.1 HRN DFC APE
gi|113194917|gb|AAF51744.3 --- DLG APE
gi|24667933|ref|NP 525001.2 H -- --- SPE
gi|28380344|gb|AAF53079.3 HGN DFG APE
gi|45446806|gb|AAF45995.2 --- --- APE
gi|24641273 HNY DPG RNL
Table 3: List of 13 rat PKLNKs. Substitutions of various important residues in the motifs which are generally conserved in the functional
protein kinase are shown for each rat PKLNK. “-” indicates deletion.
Gene code “HRD” motif in
the catalytic loop
Activation loop start Activation loop end
gi|19173772|ref|NP 596900.1 PRH --- A P E
gi|13027458|ref|NP 076490.1 HRN DFH APE
gi|16758684|ref|NP 446283.1 HGR DYG APE
gi|477540|pir||A49183 HGN DYG APE
gi|13242283|ref|NP 077356.1 HGR DHG APE
gi|204270|gb|AAA41202.1 HGN DYG APE
gi|18543337|ref|NP 570093.1 HGR DHG APE
gi|16758694|ref|NP 446290.1 HGS DYG APE
gi|109476840|ref|XP 001061647.1 HGN DPG APE
gi|149044565|gb|EDL97824.1 HGN DPG APE
gi|2288925|emb|CAA04187.1 HGN DLG APE
gi|2499669|sp|Q62689.1 HGN DPG PPE
gi|2499671|sp|Q63272.1 HGN DPG APE
such sequences is 23. This study indicates that PKLNK has
been evolved much before the divergence of prokaryote and
eukaryote.
In the current analysis, we present a detailed analysis
of the PKLNKs from four completely sequenced higher
eukaryotes, namely, Homo sapiens, Mus musculus, Rattus
norvegicus,a n dDrosophila melanogaster. An attempt has
been made to classify these PKLNKs based upon their amino
acid sequences and domain tethering preference in order to
understand molecular basis of evolution and functions of
these proteins.
2.MaterialsandMethods
In order to identify the repertoire of PKLNKs in various
eukaryotic organisms PSI-BLAST [20]s e a r c hw a sp e r f o rm e d
using traditional protein kinases as queries against the
Nonredundant Data Base (NRDB) which is a database of
protein amino acid sequences maintained at NCBI, USA.
Hits were analyzed for the absence of catalytic base aspartate
in the catalytic loop. In the PKLNKs, lacking catalytic
aspartate, we further looked for the presence of other
key-residues such as glycine in glycine-rich motif in theComparative and Functional Genomics 5
Table 4:List of 20mousePKLNKs.Substitutionsof variousimportant residues inthe motifswhich aregenerally conserved inthefunctional
protein kinase are shown for each mouse PKLNK. “-” indicates deletion.
Gene code “HRD” motif in
the catalytic loop
Activation loop start Activation loop end
gi|12839087|dbj|BAB24429.1 HRL DFG CPE
gi|21594381|gb|AAH31924.1 HRA RLG APE
gi|21703091|gb|AAM74471.1 HGN --- ---
gi|21704242|ref|NP 663596.1 HRN DFH APE
gi|21707860|gb|AAH34064.1 HGR DFG APE
gi|12858445|dbj|BAB31320.1 HRN GFE SPE
gi|20829352|ref|XP 129532.1 HNN --G S P E
gi|12963867|ref|NP 076401.1 HNN --G P P E
gi|20349229|ref|XP 111982.1 HGR DYG APE
gi|20826487|ref|XP 131378.1 HGS DYG APE
gi|20895826|ref|XP 139682.1 --- DFG APQ
gi|20869393|ref|XP 127567.1 YGH DL E ---
gi|158635954|ref|NP 113563.2 HRS --- A P E
gi|159110415|ref|NP 032218.2 HGR DHG APE
gi|28529710|ref|XP 142224.2 HGR DYG APE
gi|28804246|emb|CAD29448.2 CGN DFA PEE
gi|111607496|ref|NP 666257.2 HGN DPG APE
gi|114326478|ref|NP 001041642.1 HGN DPG PPE
gi|133922607|ref|NP 061263.2 HGN DPG APE
gi|156630890|sp|Q62137.2 HGN DPG APE
subdomain II, lysine and glutamic acid in the subdomain
III, and DFG motif in subdomain VII. However we have
considered all the kinase-like sequences lacking the catalytic
base (Asp) residue for the present analysis.
The subfamily classiﬁcation of these PKLNKs and recog-
nition of other domains in the PKLNK domain containing
multidomain proteins have been made using the procedures
and protocols developed earlier in our group in connection
with analysis of kinomes [4, 6, 21]. We have essentially
employed multiple sensitive search and analysis methods
like PSI-BLAST [20], RPS-BLAST [22], and HMMer [23]
which match sequences to Hidden Markov Models (HMMs)
of various families in Pfam (release 23) [24] to identify
various domains in the multidomain sequences. Procedure
such as PSI-BLAST has been used to detect homologues of
noncatalytic kinase like domains using an E-value cut-oﬀ
of 0.0001 that has been previously bench marked [25]. Hits
lacking signiﬁcant sequence similarity with the query have
been further examined manually.
In the current analysis, we have identiﬁed a total 82
PKLNKs in the four organisms. CD-hits program [26, 27]
was used in order to eliminate redundant sequences, which
are indicated by 100% sequence identity. So the data set is
devoid of redundant sequences.
CLUSTALW [28] has been used to align the nonenzy-
matic domains of 82 PKLNKs (see Table 1 in Supplemen-
tary Material available online at doi: 10.1155/2009/365637).
Further, catalytic domain of the protein kinase and PKLNK
domain from mouse have been aligned, and MEGA [29]w a s
used to generate phylogenetic dendrograms.
Domain assignment to the other regions apart from
the noncatalytic kinase domain of these PKLNKs has been
carried out using HMMer search methods by querying each
of the PKLNK against the 10340 protein families HMMs
available in the Pfam database (http://pfam.sanger.ac.uk/).
MulPSSM (Multiple PSSM) [30] approach was used further
to assign domain to the region which has not been assigned
using HMMer approach. Trans-membrane regions were
detected using TMHMM [31].
3. Results and Discussion
In the current analysis, we have identiﬁed 82 PKLNKs.
The main criteria used to detect these PKLNKs involve
ensuring acceptablee-valuewith proteinkinases andabsence
of catalytic base residue (Asp). There are 31 PKLNKs
identiﬁed in Homo sapiens (Table 1), 18 PKLNKs in
Drosophila melanogaster (Table 2), 13 PKLNKs in Rattus
norvegicus (Table 3), and 20 PKLNKs in Mus musculus
(Table 4). Although the catalytic Asp is absent in these
sequences, we looked for the presence or absence of other
key residues, characteristic of functional protein kinases,
in the 82 identiﬁed PKLNKs. Glycine rich loop in the
subdomainI(displayingconsensussequenceG-X-G-X-X-G)
contains at least two glycine residues in 26 gene products
(see Supplementary Table 1). The phosphorylation of the
activation segment is required for the activation of most
protein kinases that contain an Arginine (R) preceding the
catalytic base aspartate. We have essentially looked for the H-
R-X motif (where X can be any residue but cannot be D) in6 Comparative and Functional Genomics
Table 5: List of PKLNK analysed. Information on number of residues and the nearest protein kinase subfamily to which they belong to has
also been provided. Abbreviations followed in the table are RGC, Receptor guanylate cyclase; CAMK1, Ca2+/Calmodulin dependent protein
kinase 1; TSSK, Testis-speciﬁc serine/Threonine kinase; MLCK, Myosin light chain kinase; Eph, Ephrin receptor; EGFR, Epidermal growth
factor receptor; JakA, Janus kinase A; MLK, Mixed lineage kinase; Slob, SLOw Border; NRBP, Nuclear receptor binding protein; TBCK,
TBC domain-containing kinase; VRK, Vaccinia-related kinase; IRAK, IL1 receptor associated kinase; CDK, Cyclin dependent kinase; MAPK,
Mitogen activated kinase; WNK, With no K (Lysine).
PKLNK gene accession code Number of residues Closest subfamily of protein kinase
gi|40254426|ref|NP 000897.2| 1061 RGC
gi|477540|pir||A49183 333 RGC
gi|4580422|ref|NP 003986.2| 1047 RGC
gi|20826487|ref|XP 131378.1| 477 RGC
gi|16758694|ref|NP 446290.1| 1047 RGC
gi|204270|gb|AAA41202.1| 1057 RGC
gi|23093524|gb|AAN11824.1|AE003537 3 1272 RGC
gi|7294467|gb|AAF49811.1| 1172 RGC
gi|7291217|gb|AAF46649.1| 1076 RGC
gi|23171402|gb|AAF55244.2| 1417 RGC
gi|4504217|ref|NP 000171.1| 1103 RGC
gi|159110415|ref|NP 032218.2| 1108 RGC
gi|13242283|ref|NP 077356.1| 1108 RGC
gi|134152694|ref|NP 001513.2| 1108 RGC
gi|28529710|ref|XP 142224.2| 1372 RGC
gi|20349229|ref|XP 111982.1| 625 RGC
gi|16758684|ref|NP 446283.1| 1108 RGC
gi|18543337|ref|NP 570093.1| 1110 RGC
gi|28380344|gb|AAF53079.3| 1163 RGC
gi|18386335|gb|AAB19934.2| 1073 RGC
gi|21707860|gb|AAH34064.1| 754 RGC
gi|22760572|dbj|BAC11248.1| 501 CAMK1
gi|22760645|dbj|BAC11278.1| 470 CAMK1
gi|12052916|emb|CAB66632.1| 473 CAMK1
gi|21704242|ref|NP 663596.1| 512 CAMK1
gi|13027458|ref|NP 076490.1| 504 CAMK1
gi|12839087|dbj|BAB24429.1| 292 TSSK
gi|21626698|gb|AAF47134.2| 3197 MLCK
gi|4758292|ref|NP 004436.1| 1006 Eph
gi|21594381|gb|AAH31924.1| 1014 Eph
gi|17368346|sp|P83097|WSCK DROME 809 Eph
gi|119534|sp|P21860.1|ERBB3 HUMAN 1342 EGFR
gi|24641273 1177 JakA
ENSP00000294423 1156 JakA
gi|133922607|ref|NP 061263.2| 1184 JakA
gi|111607496|ref|NP 666257.2| 1153 JakA
gi|149044565|gb|EDL97824.1| 1153 JakA
gi|109476840|ref|XP 001061647.1| 1198 JakA
gi|2288925|emb|CAA04187.1| 866 JakA
ENSP00000371067 1132 JakA
gi|114326478|ref|NP 001041642.1| 1132 JakA
gi|2499669|sp|Q62689.1|JAK2 RAT 1132 JakA
gi|156630890|sp|Q62137.2|JAK3 MOUSE 1100 JakA
gi|2499671|sp|Q63272.1|JAK3 RAT 1100 JakA
ENSP00000222246 1131 JakA
ENSP00000264818 1187 JakAComparative and Functional Genomics 7
Table 5: Continued.
PKLNK gene accession code Number of residues Closest subfamily of protein kinase
gi|5052670|gb|AAD38665.1|AF145690 1 637 NRBP
gi|14042287|dbj|BAB55185.1| 535 NRBP
gi|21358011|ref|NP 651655.1| 835 SCY1
gi|7301824|gb|AAF56933.1| 873 SCY1
gi|14041796|dbj|BAB55454.1| 707 SCY1
gi|115430241|ref|NP 065731.3| 808 SCY1
gi|12963867|ref|NP 076401.1| 806 SCY1
gi|15779207|gb|AAH14662.1| 688 SCY1
gi|7243101|dbj|BAA92598.1| 796 SCY1
gi|20829352|ref|XP 129532.1| 735 SCY1
gi|113194917|gb|AAF51744.3| 2352 WNK
gi|21627748|gb|AAM68879.1| 646 Slob
gi|22945875|gb|AAN10635.1|AE003618 7 638 Slob
gi|7020363|dbj|BAA91097.1| 649 Slob
gi|20869393|ref|XP 127567.1| 582 Slob
gi|45446806|gb|AAF45995.2| 819 TBCK
gi|18676872|dbj|BAB85045.1| 893 TBCK
gi|31982929|ref|NP 057524.2| 474 VRK
gi|21703091|gb|AAM74471.1| 453 VRK
gi|24667933|ref|NP 525001.2| 448 MLK
gi|4758606|ref|NP 004508.1| 452 MLK
gi|19173772|ref|NP 596900.1| 452 MLK
gi|58530886|ref|NP 001561.3| 625 IRAK
gi|6005792|ref|NP 009130.1| 596 IRAK
gi|28804246|emb|CAD29448.2| 609 IRAK
gi|12858445|dbj|BAB31320.1| 472 Dicty4
gi|22749323|ref|NP 689862.1| 471 Dicty4
gi|16306492|ref|NP 203698.1| 240 CDK
gi|20895826|ref|XP 139682.1| 216 MAPK
gi|17862032|gb|AAL39493.1| 346 STE20
gi|13027388|ref|NP 061041.2| 418 STE20
gi|17368698|sp|Q9BXU1|STK31 HUMAN 1019 Unclassiﬁed protein kinase
gi|21357711|ref|NP 647767.1| 790 Unclassiﬁed protein kinase
gi|34191428|gb|AAH36504.2| 700 Unclassiﬁed protein kinase
gi|57997202|emb|CAD38856.2| 1491 Unclassiﬁed protein kinase
gi|158635954|ref|NP 113563.2| 1450 Unclassiﬁed protein kinase
all the 82 PKLNKs. There are 18 gene products which have
“R” of H-R-X motif conserved (see Supplementary Table
1). We further checked for the presence of DFG and APE
motifs in the activation loop and found that these motifs
are not completely conserved in 82 PKLNKs identiﬁed so far.
There are 12 and 49 protein gene products which have DFG
and APE motif conserved, respectively, (see Supplementary
Table 1).
Though these PKLNKs lack the crucial aspartate in the
catalytic loop, they are closely related to the functional
protein kinases, in terms of the sequence similarity. Table 5
provides information on the closest protein kinase subfamily
to which these PKLNKs belong to. Many of the PKLNKs
are closely related to tyrosine kinase or tyrosine kinase-like
group. Further, phylogenetic tree has been constructed
considering PKLNK domain and catalytic domain of protein
kinase subfamilies of mouse to which these PKLNKs from
mousearecloselyrelated(Figure 1).Ithasbeenobservedthat
most of the PKLNKs from mouse are grouping to protein
kinase subfamilies to which they closely belong to. This
information provides a hint about the nearest evolutionary
relation between PKLNKs and protein kinases. However,
there are two PKLNKs from mouse, one of which is closely
related to Tyrosine kinase-like group (gi|6005792), and the
other one (gi|158635954) is not closely related to any of the
known protein kinase subfamilies which are not grouping
with their closest kinase subfamilies (Figure 1) suggesting
that these two PKLNKs are evolutionary quite diverged.8 Comparative and Functional Genomics
Table 6: List of 82 PKLNKs identiﬁed from human, mouse, rat, and drosophila. Their gene accession code and domain architecture are
also provided. Abbreviations followed in the table are SH2, Src homology 2; PKLNK, Protein kinase-like nonkinase, Pkinase, Protein kinase;
Guanylate cyc, Guanylate cyclase; TM, Transmembrane; Ank, Ankyrin; SAM, Sterile alpha motif; PX, Phox; I-set, Immunoglobulin; fn3,
Fibronectin type III; Ephrin lbd, Ephrin receptor ligand binding domain.
Gene accession code Domain name, boundary, and E-value
ENSP00000222246 SH2, 377 457 0.0066 ∗ PKLNK, 822 1071 2e-27 ∗
ENSP00000264818 PKLNK, 589 866 4.9e-10 ∗ Pkinase, 897 1172 1.2e-44 ∗
ENSP00000294423 SH2, 441 526 0.0016 ∗ PKLNK, 583 847 1e-12 ∗ Pkinase, 877 1151 2.1e-40 ∗
ENSP00000371067 SH2, 401 481 0.00012 ∗ PKLNK, 545 805 2.6e-10 ∗ Pkinase, 849 1123 4.4e-42 ∗
gi|109476840|ref|XP 001061647.1| SH2, 486 570 0.0016 ∗ PKLNK, 627 889 1.5e-12 ∗ Pkinase, 919 1193 3.5e-39 ∗
gi|111607496|ref|NP 666257.2| SH2, 441 525 0.0038 ∗ PKLNK, 582 844 1.8e-12 ∗ Pkinase, 874 1148 4.5e-39 ∗
gi|113194917|gb|AAF51744.3| PKLNK, 444 650 2.4e-21 ∗
gi|114326478|ref|NP 001041642.1| SH2, 401 481 0.00014 ∗ PKLNK, 545 805 1.5e-09 ∗ Pkinase, 849 1123 5.2e-43 ∗
gi|115430241|ref|NP 065731.3| PKLNK, 29 259 4e-88 ∗ HEAT, 383 419 0.0067 ∗ HEAT, 501 537 3.2e-05 ∗
gi|119534|sp|P21860.1|ERBB3 HUMAN Recep L domain, 55 167 6.7e-45 ∗ Furin-like, 180 332 3.4e-79 ∗ Recep L domain,
353 474 3.4e-46 ∗ TM, o644 666i ∗ PKLNK, 709 965 1.9e-24 ∗
gi|12052916|emb|CAB66632.1| PKLNK, 24 258 2.2e-38 ∗
gi|12839087|dbj|BAB24429.1| PKLNK, 25 289 6e-55 ∗
gi|12858445|dbj|BAB31320.1| PKLNK, 195 461 5e-11 ∗
gi|12963867|ref|NP 076401.1| PKLNK, 29 301 0.00098 ∗ HEAT, 383 419 0.014 ∗ HEAT, 501 537 0.00015 ∗
gi|13027388|ref|NP 061041.2| PKLNK, 58 369 2e-28 ∗
gi|13027458|ref|NP 076490.1| PKLNK, 24 286 9.9e-70 ∗
gi|13242283|ref|NP 077356.1| ANF receptor, 75 411 5.3e-59 ∗ TM, o468 490i ∗ PKLNK, 520 808 1.8e-09 ∗
Guanylate cyc, 874 1061 2.2e-92 ∗
gi|133922607|ref|NP 061263.2| PKLNK, 589 863 1.7e-10 ∗ Pkinase, 894 1166 4.5e-43 ∗
gi|134152694|ref|NP 001513.2| ANF receptor, 71 412 3.1e-83 ∗ TM, o468 490i ∗ PKLNK, 532 809 3.1e-14 ∗
Guanylate cyc, 875 1062 3.4e-92 ∗
gi|14041796|dbj|BAB55454.1| PKLNK 29 259 9e-89 ∗ HEAT, 383 419 0.0067 ∗ HEAT, 501 537 3.2e-05 ∗
gi|14042287|dbj|BAB55185.1| PKLNK, 81 327 3.2e-08 ∗
gi|149044565|gb|EDL97824.1| SH2, 441 525 0.0016 ∗ PKLNK, 582 844 1.5e-12 ∗ Pkinase, 874 1148 3.5e-39 ∗
gi|156630890|sp|Q62137.2|JAK3 MOUSE PKLNK, 818 1091 2.1e-37 ∗
gi|15779207|gb|AAH14662.1| PKLNK, 18 245 0.00017 ∗
gi|58635954|ref|NP 113563.2| Ank, 55 87 0.00011 ∗ Ank, 88 120 0.018 ∗ PKLNK, 251 503 2e-06 ∗
gi|159110415|ref|NP 032218.2| ANF receptor, 75 411 1.1e-56 ∗ TM, o345 364i ∗ PKLNK, 520 811 2.3e-09 ∗
Guanylate cyc, 874 1061 7e-92 ∗
gi|16306492|ref|NP 203698.1| PKLNK, 4 230 8.7e-56 ∗
gi|16758684|ref|NP 446283.1| ANF receptor, 71 412 2.8e-74 ∗ TM, o468 490i ∗ PKLNK, 532 809 8.6e-11 ∗
Guanylate cyc, 875 1062 2.2e-92 ∗
gi|16758694|ref|NP 446290.1| ANF receptor, 44 400 5.9e-75 ∗ TM, o456 478i ∗ PKLNK, 534 786 5.3e-17 ∗
Guanylate cyc, 852 1038 5.6e-107 ∗
gi|17368346|sp|P83097|WSCK DROME TM, i12 34o ∗ WSC, 42 115 3.8e-25 ∗ fn3, 129 233 2e-05 ∗ TM, o422 444i ∗
PKLNK, 511 768 2.6e-10 ∗
gi|17368698|sp|Q9BXU1|STK31 HUMAN TUDOR, 28 147 2e-31 ∗ PKLNK, 739 972 3.6e-05 ∗
gi|17862032|gb|AAL39493.1| PKLNK, 10 298 3.7e-11 ∗
gi|18386335|gb|AAB19934.2| ANF receptor, 53 386 3.9e-32 ∗ TM, o432 454i ∗ PKLNK, 497 745 1.1e-09 ∗
Guanylate cyc, 815 1002 1.5e-104 ∗
gi|18543337|ref|NP 570093.1| ANF receptor, 88 422 7e-71 ∗ TM, o480 502i ∗ PKLNK, 550 818 2.4e-11 ∗
Guanylate cyc, 884 1071 1.4e-90 ∗
gi|18676872|dbj|BAB85045.1| PKLNK, 26 273 3.4e-18 ∗ TBC, 463 673 1.1e-10 ∗ Rhodanese, 776 883 9.2e-09 ∗
gi|19173772|ref|NP 596900.1| Ank, 33 65 9.4e-09 ∗ Ank, 66 98 1.6e-09 ∗ Ank, 99 131 3.2e-07 ∗ PKLNK, 193 449
1.5e-10 ∗
gi|20349229|ref|XP 111982.1| PKLNK, 1 214 2e-08 ∗ Guanylate cyc, 306 521 1.2e-79 ∗
gi|204270|gb|AAA41202.1| ANF receptor, 50 412 1.3e-80 ∗ PKLNK, 534 797 8.4e-13 ∗ Guanylate cyc, 863 1049
6e-109 ∗Comparative and Functional Genomics 9
Table 6: Continued.
Gene accession code Domain name, boundary, and E-value
gi|20826487|ref|XP 131378.1| PKLNK, 1 216 7e-09 ∗ Guanylate cyc, 282 468 5.6e-107 ∗
gi|20829352|ref|XP 129532.1| PKLNK, 18 245 8.9e-05 ∗
gi|20869393|ref|XP 127567.1| PX, 17 122 2.4e-19 ∗ PKLNK, 146 443 0.0012 ∗
gi|20895826|ref|XP 139682.1| PKLNK, 4 206 3.7e-06 ∗
gi|21357711|ref|NP 647767.1| PKLNK, 406 658 0.0018 ∗
gi|21358011|ref|NP 651655.1| PKLNK, 31 314 5.7e-09 ∗
gi|21594381|gb|AAH31924.1| TM, i13 32o ∗ Ephrin lbd, 34 227 4.5e-113 ∗ fn3, 365 463 1.8e-06 ∗ fn3, 481 565
1.3e-17 ∗ TM, o590 612i ∗ PKLNK, 663 908 7.4e-22 ∗ SAM, 938 1005 1.6e-22 ∗
gi|21626698|gb|AAF47134.2|
I-set, 2 87 2.1e-06 ∗ I-set, 102 195 6.9e-17 ∗ I-set, 203 278 0.00011 ∗ I-set, 292 382
7.6e-23 ∗ I-set, 385 479 2.6e-05 ∗ I-set, 483 574 2.6e-15 ∗ I-set, 578 669 6.2e-11 ∗
I-set, 673 765 7.1e-20 ∗ I-set, 800 884 3.1e-10 ∗ I-set, 893 993 0.00015 ∗ I-set, 997
1087 2.5e-10 ∗ I-set, 1092 1194 1.3e-05 ∗ I-set, 1199 1290 2.1e-21 ∗ I-set, 1297 1387
7.4e-24 ∗ I-set, 1394 1485 7.3e-23 ∗ I-set, 1498 1587 4.6e-21 ∗ I-set, 1594 1683
1.1e-18 ∗ I-set, 1696 1786 1.1e-21 ∗ fn3, 1812 1898 9.9e-07 ∗ I-set, 1951 2042
0.00043 ∗ I-set, 2046 2136 7.1e-12 ∗ PKLNK, 2165 2419 2.5e-48 ∗ I-set, 2633 2723
1.2e-17 ∗ fn3, 2727 2809 1.2e-12 ∗ PKLNK, 2876 3130 1.7e-34 ∗
gi|21627748|gb|AAM68879.1| PX, 17 122 7.9e-15 ∗ PKLNK, 146 435 0.00023 ∗
gi|21703091|gb|AAM74471.1| PKLNK, 145 439 e-128 ∗
gi|21704242|ref|NP 663596.1| PKLNK, 24 286 3.4e-70 ∗
gi|21707860|gb|AAH34064.1| TM, o114 136i ∗ PKLNK, 176 426 3.7e-10 ∗Guanylate cyc, 496 683 2e-99 ∗
gi|22749323|ref|NP 689862.1| PKLNK, 209 466 1e-13 ∗
gi|22760572|dbj|BAC11248.1| PKLNK, 24 286 7.8e-67 ∗
gi|22760645|dbj|BAC11278.1| PKLNK, 24 286 3.4e-70 ∗
gi|2288925|emb|CAA04187.1| SH2, 313 397 0.00056 ∗ PKLNK, 454 716 3.2e-14 ∗
gi|22945875|gb|AAN10635.1|AE003618 7 PKLNK, 304 520 ∗
gi|23093524|gb|AAN11824.1|AE003537 3 ANF receptor, 64 447 8e-33 ∗ PKLNK, 610 869 4.4e-16 ∗ Guanylate cyc, 935 1121
1.5e-89 ∗
gi|23171402|gb|AAF55244.2| ANF receptor, 107 473 1.2e-83 ∗ PKLNK, 608 877 1.8e-15 ∗ Guanylate cyc, 944
1130 9.7e-103 ∗
gi|24667933|ref|NP 525001.2| Ank, 33 65 1.6e-07 ∗ Ank, 66 98 1.4e-06 ∗ Ank, 99 131 1.5e-08 ∗ PKLNK, 192 446
6.9e-09 ∗
gi|2499669|sp|Q62689.1|JAK2 RAT SH2, 401 481 8.6e-05 ∗ PKLNK, 545 805 8.9e-10 ∗ Pkinase, 849 1123 1.9e-43 ∗
gi|2499671|sp|Q63272.1|JAK3 RAT PKLNK, 818 1091 2.7e-38 ∗
gi|28380344|gb|AAF53079.3| ANF receptor, 57 398 2e-37 ∗ PKLNK, 529 798 3e-11 ∗ Guanylate cyc, 864 1050
3.3e-88 ∗
gi|28529710|ref|XP 142224.2| ANF receptor, 166 499 3.7e-62 ∗ PKLNK, 647 926 1.5e-10 ∗ Guanylate cyc, 1018
1229 2.4e-72 ∗
gi|28804246|emb|CAD29448.2| Death, 26 106 5.1e-18 ∗ PKLNK, 178 456 1e-17 ∗
gi|31982929|ref|NP 057524.2| PKLNK, 202 460 0.0082 ∗
gi|34191428|gb|AAH36504.2| PKLNK, 48 317 7.9e-14 ∗
gi|40254426|ref|NP 000897.2| ANF receptor, 54 416 2.7e-79 ∗ PKLNK, 538 801 3.7e-11 ∗ Guanylate cyc, 867 1053
7e-110 ∗
gi|4504217|ref|NP 000171.1| ANF receptor, 72 408 1.3e-55 ∗ TM, o465 487i∗ PKLNK, 517 805 8.8e-10 ∗
HNOBA, 718 870 0.009 ∗ Guanylate cyc, 871 1058 1.8e-89 ∗
gi|45446806|gb|AAF45995.2| PKLNK, 18 263 1.2e-07 ∗ TBC, 430 636 1.4e-08 ∗
gi|4580422|ref|NP 003986.2| ANF receptor, 44 400 2.7e-75 ∗ PKLNK, 534 786 3.2e-18 ∗ Guanylate cyc, 852 1038
5.6e-107 ∗
gi|4758292|ref|NP 004436.1| Ephrin lbd, 18 217 4.5e-110 ∗ fn3, 355 455 1.8e-06 ∗ fn3, 473 557 3.2e-18 ∗ TM,
o582 604i ∗ PKLNK, 655 900 1.1e-22 ∗ SAM, 930 997 6e-22 ∗
gi|4758606|ref|NP 004508.1| Ank, 33 65 9.4e-09 ∗ Ank, 66 98 1.6e-09 ∗ Ank, 99 131 3.2e-07 ∗ PKLNK, 193 449
1.3e-10 ∗
gi|477540|pir||A49183 PKLNK, 16 250 7.9e-07 ∗10 Comparative and Functional Genomics
Table 6: Continued.
Gene accession code Domain name, boundary, and E-value
gi|5052670|gb|AAD38665.1|AF145690 1 PKLNK, 122 375 4.7e-09 ∗
gi|57997202|emb|CAD38856.2| Ank, 55 87 0.0025 ∗ Ank, 88 120 0.0056 ∗ PKLNK, 251 503 1.6e-06 ∗
gi|58530886|ref|NP 001561.3| Death, 14 94 2.9e-16 ∗ PKLNK, 210 496 2.6e-11 ∗
gi|6005792|ref|NP 009130.1| Death, 26 106 4.4e-18 ∗ PKLNK, 165 443 3e-12 ∗
gi|7020363|dbj|BAA91097.1| PX, 17 122 1.3e-16 ∗ PKLNK, 146 449 0.0028 ∗
gi|7243101|dbj|BAA92598.1| PKLNK, 4 190 2e-63 ∗
gi|7291217|gb|AAF46649.1| ANF receptor, 107 481 1.4e-73 ∗ PKLNK, 555 794 3.9e-10 ∗ Guanylate cyc, 860
1046 1.2e-99 ∗
gi|7294467|gb|AAF49811.1| ANF receptor, 64 423 3.9e-35 ∗ PKLNK, 573 832 4.4e-16 ∗ Guanylate cyc, 898 1084
1.5e-89 ∗
gi|7301824|gb|AAF56933.1| PKLNK, 28 268 2e-82 ∗ HEAT, 383 419 0.0027 ∗
gi|24641273 PKLNK, 892 1151 1.4e-35 ∗
Table 7: Frequency of domain families tethered to the PKLNKs.
Domain name Number of gene
products Number of domains
ANF receptor 17 17
Guanylate cyclase 20 20
Protein kinase 9 9
Ankyrin 5 13
Fibronectin 3 4 7
Heat 4 7
Immunoglobulin I-set 1 21
Phox 3 3
TBC 2 2
Receptor L domain 1 2
Furin-like 1 1
Death 3 3
Ephrin receptor ligand
binding domain 22
Sterile Alpha Motif 2 2
WSC 1 1
Rhodanese 1 1
Tudor 1 1
Transmembrane
domain 13 15
3.1. Accessory Domains Tethered to the PKLNKs. In the
multidomain proteins a given domain acts in conjunction
with other domains which are tethered together in the same
polypeptide chain and help in their regulation. Absence of
catalytic aspartate in the active site reﬂects the noncatalytic
activity of PKLNKs, but domain organization of a protein
can give clues about putative functional roles. Domains
tethered to PKLNKs suggest that though these PKLNKs
lack key catalytic residues, they are involved in protein-
protein interactions and might have important regulatory
roles in signal transduction pathway. In the current analysis
we have identiﬁed 19 diﬀerent types of domains tethered
to the PKLNK domain. Except 24 PKLNKs, majority of
PKLNKs identiﬁed have accessory domains tethered to them
(Table 6). The Pfam domains tethered to PKLNK domain
and their frequency of occurrence are represented in Table 7.
As can be seen in Table 7, the most commonly tethered
domains areANF receptordomain, Transmembranedomain
and Guanylate cyclase domains. Interestingly most of the
time it has been observed that all the three domains are
present in the same polypeptide. There are some domain
families which occur in repeats like Immunoglobulin I-
set domain and HEAT domain which are mainly involved
in cell-cell recognition, and protein-protein interactions,
respectively, have also been found tethered to the PKLNK
domain. Prediction of transmembrane domain has revealed
occurrence of receptor PKLNKs which have most of the time
single pass transmembrane region. Interestingly a drosophila
protein (gi|21626698) has two PKLNK domains, many I-
set (Immunoglobulin) repeats and fn3 domains which has
been observed for the ﬁrst time (Figure 2(a)) and not seen
in any functional protein kinase. Our study has revealed that
these two PKLNK domains are closely related to myosin light
chain kinase subfamily of calcium/calmodulin dependent
kinase group. There are a few PKLNKs which are closely
related to receptor guanylate cyclase family of protein kinase
whichischaracterizedbyextracellularANFreceptordomain.
Interestingly some of these PKLNKs which are closely related
to receptor guanylate cyclase subfamily of protein kinase do
not have extracellular domain predicted in the N-terminal
(Figure 2(b)) suggesting evolutionary paradigm.
Based upon the broad function, the domains tethered to
PKLNK can be functionally categorized into four categories:
(1) Domainswhicharemainlyinvolvedinligandbinding
like ANF receptor, Receptor L domain, and Ephrin
receptor ligand binding domain.
There are 17 gene products which have domains architecture
similar to ANP receptor [12] in which ANF receptor is
followed by PKLNK which is followed by Guanylate cyclase
domain. The ANF receptor is an extracellular ligand binding
domain in a wide range of receptors [33]. Guanylate
cyclase catalyses the formation of cyclic GMP (cGMP) from
GTP which acts as intracellular messenger and regulatesComparative and Functional Genomics 11
Table 8: Common and unique domain structures of PKLNKs and protein kinases encoded in the data set of genomes. Abbreviations
followed in the table are Mad3 BUB1 I, Mad3/BUB1 homology region 1; Pkinase, Protein kinase; PKLNK, Protein kinase-like nonkinase;
TM, Transmembrane; SH2, Src-homology 2; I-set, Immunoglobulin; Ank, Ankyrin; fn3, Fibronectin type III; Ephrin lbd, Ephrin receptor
ligand binding domain; SAM, Sterile alpha motif; HNOBA, Heme NO binding associated; Guanylate cyc, Guanylate cyclase.
Domain structure unique to
PKLNKs
Domain structure unique
to protein kinases Domain structure common to protein kinases and PKLNKs
PKLNK, HEAT × 2 TM, ANF receptor,
Pkinase, Guanylate cyc SH2, PKLNK, Pkinase
Ank × 2, PKLNK I-set × 2, Pkinase Recep L domain, Furin-like, Recep L domain, TM, PKLNK
TUDOR, PKLNK Mad3 BUB1 I, Pkinase PKLNK, Pkinase
ANF receptor, TM, PKLNK,
HNOBA, Guanylate cyc Ank × 3, Pkinase TM, WSC, fn3, TM, PKLNK
ANF receptor, TM, PKLNK, Guanylate cyc
PKLNK, TBC, Rhodanese
PKLNK, Guanylate cyc
TM, Ephrin lbd, fn3 × 2, TM, PKLNK, SAM
I-set × 18, fn3, I-set × 2, PKLNK, I-set, fn3, PKLNK
TM, PKLNK, Guanylate cyc
SH2, PKLNK
ANF receptor, PKLNK, Guanylate cyc
PKLNK, TBC
Ephrin lbd, fn3 × 2, TM, PKLNK, SAM
Death, PKLNK
PX, PKLNK
PKLNK, HEAT
various cellular processes like smooth muscle relaxation,
retinalphototransduction,regulationofionchannels,andso
forth [34, 35]. The ephrin receptor ligand-binding domain
(EPH lbd) which binds to ephrin is a large family of
receptor tyrosine kinases. Biochemical studies suggest that
the multimerization of EPH lbd modulates the cellular
response and acts on actin cytoskeleton [36].
(2) Domains which are extracellular and involved in
protein-protein interactions like I-set (Immunoglob-
ulin like domain) and Fn3 (Fibronectin type III)
domains.
(3) Domains involved in dimerization like Death
domain, SAM (Sterile Alpha Motif) domain, and
Furin-like domain.
Proteins containing death domains are well known to
participate in the signaling events which regulate apoptosis
[37] indicating role of PKLNK in apoptosis. Proteins con-
taining SAM domains are involved in homo- and hetero
oligomerization with other SAM domains and are involved
in various developmental processes [38]. Furin-like domain
is found tethered to receptor tyrosine kinase. It is rich in
cysteine and involved in receptor aggregation.
(4) Domains involved in protein-protein interactions
like Ank (Ankyrin repeats) and Heat repeats.
Ank is one of the most common protein-protein interaction
modules which occur in large number of functionally
diverse proteins. PKLNKs containing Ank repeat are likely
to play role in diverse functions like signal transduction, ion
transportation, transcription initiation, and so forth. Heat
domain is 30–40 amino acid tandemly repeated domain.
PKLNK containing Heat domain might have role in intra-
cellular transport processes.
Apart from the domains discussed above there are some
more accessory domains found tethered to the PKLNK
domain which provide functional diversity to the PKLNKs.
A human PKLNK (gi|18676872) has TBC domain and
Rhodanese domain in the C-terminal. TBC domain is
involved in GTPase signaling, and Rhodanese domain which
shares evolutionary relationship with large family of protein
is involved in cyanide detoxiﬁcation [39]. Another human
PKLNK (gi|17368698) has TUDOR domain N-terminal to
the PKLNK domain which indicates its role in RNA binding
[40] which has so far not seen tethered with protein kinase
(Figure 2(c)).
A drosophila PKLNK (gi|17368346) has WSC domains
N-terminal to the PKLNK domain which is likely to be an
extracellular carbohydrate binding domains. At least three
PKLNKs (gi|20869393, gi|21627748, gi|7020363) have PX
domainN-terminaltothePKLNKdomainwhichmighthave
role in lipid signaling.
Phylogenetic tree has been generated by considering
the nonenzymatic PKLNK domains of these 82 PKLNKs
(Figure 3) in which interestingly we have observed some
clusters having similar domain organization. Some of the
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Table 9: List of PKLNKs which interact with a large number of proteins. The in vivo/in vitro protein-protein interaction data has been
obtained from HPRD database [32].
PKLNK Accession code of the
interacting protein Name Role
NP 009130.1
NP 001560 Interleukin-1 receptor-associated
kinase 1 isoform 1
Partially responsible for IL1-induced
upregulation of the transcription factor
NF-kappa B
NP 001561 Interleukin-1 receptor-associated
kinase 2
Participate in the IL1-induced upregulation
of NF-kappa B
NP 002459 Myeloid diﬀerentiation primary
response gene 88
Functions as adapter protein in the
association of IL-1 receptor associated
kinase (IRAK) with the IL-1 receptor
NP 067681 Toll-like receptor adaptor molecule 2 Involved in Toll receptor siganling
NP 665802 TNF receptor-associated factor 6
Mediates signal transduction from members
of the TNF receptor superfamily and from
the members of the Toll/IL-1 family
NP 004436.1
NP 001035090 Myeloid/lymphoid or mixed-lineage
leukemia
Regulates cell-cell adhesions downstream of
Ras activation
NP 002077 Growth factor receptor-bound protein
2i s o f o r m1
Binds epidermal growth factor receptor.
Involved in signal transduction pathway
NP 002961 Spermidine/spermine
N1-acetyltransferase
Involved in the catabolic pathway of
plymine metabolism
NP 004084 Ephrin B2 Mediates developmental events, especially in
the nervous system and in erythropoiesis
NP 004432 Ephrin receptor EphB1 precursor Mediates developmental events, especially in
the nervous system and in erythropoiesis
NP 005179 Cas-Br-M (murine) ecotropic
retroviral transforming sequence
A d a p t o rp r o t e i nf o rr e c e p t o r
protein-tyrosine kinases, positively regulates
receptor protein-tyrosine kinase
ubiquitination in a manner dependent upon
its variant SH2 and RING ﬁnger domains
NP 005198 v-crk sarcoma virus CT10 oncogene
homolog Plays a role in ﬁbroblast transformation
NP 058431 v-crk sarcoma virus CT10 oncogene
homolog isoform a
Member of an adapter protein family that
binds to several tyrosine-phosphorylated
proteins
NP 115500 Haloacid dehalogenase-like hydrolase
domain containing 2 Hydrolase
NP 004508.1 AAM77350 LIMS2
Is a focal adhesion protein that associates
with integrin-linked kinases and involved in
protein-protein interactions at adhesion
sites between cells and the extracellular
matrix
BAA18998 Paxillin gamma
A focal adhesion complex (FAC) which
interacts with a wide array of molecules
involved in managing the cells response to
extracellular matrix components, growth
factors, cell : cell interactions, and
chemotatic signals.
NP 000202 Integrin, beta 2 precursor
Cell-surface protein participates in cell
adhesion as well as cell-surface mediated
signaling
NP 000203 Integrin beta chain, beta 3 Participates in cell adhesion as well as
cell-surface mediated signaling
NP 001003828 Parvin, beta isoform a Actin-binding proteins associated with focal
contactsComparative and Functional Genomics 13
Table 9: Continued.
PKLNK Accession code of the
interacting protein Name Role
NP 001744 Caveolin 1
Main component of the caveolae plasma
membranes, links integrin subunits to the
tyrosine kinase FYN which helps in cell cycle
progression
NP 002084 Glycogen synthase kinase 3 beta
Involved in energy metabolism, neuronal
cell development, and body pattern
formation
NP 002471 Protein phosphatase 1, regulatory
(inhibitor) subunit 12A
Regulates interaction of actin and myosin
downstream of the guanosine
triphosphatase Rho
NP 002604 3-phosphoinositide dependent protein
kinase-1 isoform 1
Phosphorylates and activates protein kinase
B alpha and p70 S6 kinase
NP 004978 LIM and senescent cell antigen-like
domains 1
Adaptor protein which may play role in
integrin-mediated cell adhesion pr
spreading
NP 005154 v-akt murine thymoma viral oncogene
homolog 1
Mediator of growth factor-induced neuronal
survival
NP 060692 Parvin, alpha Actin-binding protein associated with focal
contacts
NP 066932 Thymosin, beta 4
Plays a role in regulation of actin
polymerization, cell proliferation,
migration, and diﬀerentiation
NP 071424 Parvin, gamma Actin-binding proteins associated with focal
contacts
NP 110395 Integrin-linked kinase-associated
protein phosphatase 2C
Regulates the kinase activity of
integrin-linked kinase and participate in
Wnt signaling
NP 391987 Integrin beta 1 isoform 1C-1 precursor
Involved in cell adhesion and recognition in
a variety of processes including
embryogenesis, hemostasis, tissue repair,
immune response, and metastatic diﬀusion
of tumor cells.
NP 000171.1
NP 000400 Guanylate cyclase activator 1A (retina) Activator of guanylate cyclase
NP 002089 Guanylate cyclase activator 1B (retina) Activator of guanylate cyclase
NP 006263 S100 calcium-binding protein, beta Involved in cell cycle progression and
diﬀerentiation
NP 009033 Guanylate cyclase activator 2B Activator of guanylate cyclase receptor
O75916 Regulator of G-protein signaling 9
Inhibits signal transduction by increasing
the GTPase activity of G-protein alpha
subunits, involved in phosphotransduction
NP 003986.2 NP 003986 Natriuretic peptide receptor B
precursor
Primary receptor for C-type natriuretic
peptide, which upon ligand binding exhibits
greatly increased guanylyl cyclase activity
NP 077720 Natriuretic peptide precursor C
Possesses potent natriuretic, diurectic, and
vasodilating activities and are implicated in
body ﬂuid homeostasis and blood pressure
control
NP 061041.2 NP 000446 Serine/threonine protein kinase 11 Regulates cell polarity and functions as a
tumor suppressor
NP 001158 Baculoviral IAP repeat-containing
protein 4
Inhibits apoptosis through binding to tumor
necrosis factor receptor-associated factors
TRAF1 and TRAF2
NP 057373 Calcium binding protein 39 Calcium binding14 Comparative and Functional Genomics
Table 9: Continued.
PKLNK Accession code of the
interacting protein Name Role
NP 663304 Mitogen-activated protein kinase
kinase kinase 7 isoform B
Mediates signal transduction induced by
TGF beta and morphogenetic protein and
controls variety of cell functions including
transcription regulation and apoptosis
NP 665802 TNF receptor-associated factor 6
Mediates signal transduction from members
of the TNF receptor superfamily and from
the members of the Toll/IL-1 family
NP 065731.3
NP 004636 Coilin
The protein encoded by this gene is an
integral component of Cajal bodies (also
called coiled bodies). Cajal bodies are
nuclear suborganelles of varying number
and composition that are involved in the
posttranscriptional modiﬁcation of small
nuclear and small nucleolar RNAs.
NP 036204 CD93 antigen precursor Involved in intercellular adhesion and in the
clearance of apoptotic cells
NP 689494 SCY1-like 1 binding protein 1 Known to interact with SCY1-like family of
kinase-like proteins
NP 001513.2 NP 001513.2 Guanylate cyclase 2F Probably plays a speciﬁc functional role in
the rods and/or cones of photoreceptors.
NP 002089 Guanylate cyclase activator 1B (retina) Activator of guanylate cyclase
NP 000897.2
NP 006249 Protein kinase, cGMP-dependent, type
Ii s o f o r m2 Protein phosphorylation
NP 002512 Natriuretic peptide precursor B
preproprotein
Functions as cardiac hormone, has role in
natriuresis, diuresis, vasorlaxation
inhibition of rennin, and aldosterone
secretion, and has a key role in
cardiovascular homeostasis
NP 000897 Natriuretic peptide receptor 1
Membrane bound guanylate cyclase that
serves as the receptor for both atrial and
brain natriuretic peptides
NP 006163 Natriuretic peptide precursor A
Potent natriuretic, diuretic, and vasodilating
activities and are implicated in body ﬂuid
homeostasis and blood pressure control
NP 060649 Activating transcription factor 7
interacting protein
Modulates transcription regulation and
chromatin formation
various colours. It can be noticed that, in general, PKLNKs
with similar domains tethered are clustered together in
Figure 3. There are few PKLNKs which have only one
domain, and other parts of the sequences have not been
assigned to any other Pfam domains. There are 20 PKLNKs
which have guanylate cyclase domains tethered in the C-
terminus (represented in green in Figure 3). There are
13 PKLNK sequences which have SH2 (Src homology 2)
domain in the N-terminus (represented in red in Figure 3).
SH2 domain functions as regulatory module of intracellular
signalingcascadebyinteractingwiththephosphopeptide.All
of these SH2 containing PKLNKs except one (gi|2288925)
have protein kinase domain tethered in the C-terminus.
These 12 protein kinases domains are close homologues of
protein tyrosine kinase 7 subfamily. This kind of domain
architecture having SH2 domain followed by PKLNK which
is followed by protein kinase domain has not been reported
anywhere to the best of our knowledge. However, JAK1
(Janus kinase 1) has very similar domain combination in
whichapartfromthesethreedomains,FERMdomainwhich,
isinvolvedinbindingtocytokinereceptors[32,41]ispresent
in the N-terminus [42].
The biological function of these PKLNKs might be in the
regulation of tyrosine protein kinase activity.
Further, we have compared the domain structure of
PKLNKs and their closest protein kinase subfamilies. Inter-
estingly, we have observed that there are a few domain
combinations which are unique to either PKLNKs or protein
kinases. There are a few Pfam domains such as TUDOR
and HNOBA (Heme NO binding associated) which have not
been seen tethered to protein kinase domains so far. HNOBA
domain is known to function as heme-dependent sensor for
gaseous ligands and transduce diverse downstream signals
across diverse organisms [43]. The domain structures which
commonly occur between PKLNK and protein kinase have
also been studied (Table 8).Comparative and Functional Genomics 15
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Figure 3: The dendrogram generated by considering the nonenzymatic protein kinase-like nonkinase domains. Various sequences having
similar domain organization are represented in diﬀerent colours: Green: PKLNK having Guanylate Cyclase (GC) domain in the C-terminus;
Pink:AnkyrinrepeattetheredtothePKLNK;Cyan:Ephrin lbd,fn3,SterilAlphaMotif(SAM)tetheredtothePKLNK;Purple:Deathdomain
tethered to the PKLNK; Blue: Phox (PX) domain tethered to the PKLNK; Brown: Heat domain tethered to the PKLNK; Red: Src Homology
2 (SH2) tethered to the PKLNK.
3.2. Protein-Protein Interaction of Human PKLNKs. Under-
standing the biological roles of proteins in the cellular
environment is the main aim of genome analysis. For
almost all cellular processes in a living cell protein-protein
interactionsareofcentralimportance.Inthecurrentsection,
we have focused on human PKLNKs. We have looked for
the protein-protein interactions of PKLNKs using HPRD
database (http://www.hprd.org/)[ 44]. At least 9 human
PKLNKs are shown to interact with various other proteins
(Table 9) and most of these proteins are signaling proteins
and adapter proteins which module the cell signaling and
play critical role in cell polarization, diﬀerentiation, cell
adhesion, neuronal cell development, apoptosis, homeosta-
sis, and so forth. Four of these nine PKLNKs which are
closely related to receptor guanylate cyclase (RGC) family of
protein kinase are reported to interact mainly with natri-
uretic peptide and guanylate cyclase. The protein-protein
interaction informations obtained from HPRD emphasize
role of PKLNKs in signaling.
4. Conclusions
This work represents functional analysis of noncatalytic
PKLNKs across a data set of 82 PKLNKs from four higher
eukaryotes. Our analysis has indicated that existence of
noncatalytic PKLNKs is quite common. The fact that
noncatalytic PKLNKs are well conserved between Homo
sapiens, Mus musculus, Rattus norvegicus,a n dDrosophila16 Comparative and Functional Genomics
melanogaster strongly argues against pseudogenes, as oth-
erwise these would have been lost during the evolutionary
time. Our study on PKLNKs suggests that most noncatalytic
PKLNKsarederivedfromactiveproteinkinaseancestorsand
have lost one or more of the critical catalytic residues within
theactivesitewhichprovidesnewinsightintonature’swayof
eliciting new functions of PKLNKs. Based upon the domain
tethering preferences we have classiﬁed PKLNKs into four
mainclassesinwhichmembersofthetwoclassesarereceptor
PKLNKs which are mainly involved in ligand binding and
protein-protein interaction extracellularly while other two
classes of PKLNKs have members which are cytoplasmic,
and they are mainly involved in dimerization and protein-
protein interaction in the cytoplasm. The phylogenetic
analysis reveals function-based clustering of these PKLNKs.
Conservationofsomeofthemodularorganizationacrossthe
four organisms suggests their central role in the eukaryotic
signaling pathway. Since many of the PKLNKs have other
domains tethered to them and are involved in protein-
protein interactions, one can speculate that though the
kinase-like domain is nonenzymatic, they might have role
in regulation and scaﬀolding. Some of these catalytically
inactive members of PKLNKs which are close homologues of
the receptor tyrosine kinase are shown to be over-expressed
in cancer cells. Additional studies are required to determine
precise function and role of these PKLNKs in tumorgenesis
and its usefulness in the diagnosis of tumors. Domain
organization of these PKLNKs revealed that some of the
PKLNKs have new and hence unique domain organization
so far not seen in any other family of gene products. 3D
structure and biochemical analysis can further determine
and explore the functional role of these PKLNKs. The
presence of putative PKLNK in higher eukaryotes indicates
that we have more to learn about cellular signaling involving
these noncatalytic domains. Evolutionary history of these
PKLNKs would be of particular interest. It is hoped that
this analysis will provide a better understanding about the
frequent occurrence of PKLNKs in diﬀerent organisms and
hence their function.
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